|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS |
 |
| |
|
|
|
|
| PMPS Editor, Patricia Lobo, takes a look at articles in this issue |
|
|
|
| In Employing Negative Pressure to Achieve a Positive Result: Dust Control in the Pharmaceutical Industry, David Clarkson, Sales Director at Dust Extraction International Ltd, evaluates the unique control needs of the pharmaceutical industry |
|
|
| Cleaning verification is an essential component to GMP, as it ensures the high standards of manufacturing equipment during the process, contends Dr Raymond Munden, Pharmaceutical Development Consultant at Smiths Detection, in Using Ion Mobility Spectrometry: An Improved Approach to Cleaning Verification |
|
|
|
|
| Peter Tindale, Product Manager for ITW Induction Sealing, discusses the well-established method of induction sealing for applying hermetic foil seals to pharmaceutical containers, in Maximising Performance and Eliminating Variables |
|
|
Among the many demands being placed on the manufacturing industry, the most pressing of all is finding a way to ensure efficient component tracebility, as Leigh Simpson, International ID Product Marketing Specialist at Cognex UK Ltd, puts forward in Complete Product Traceability
|
|
|
|
| Kal Venkataraman, Process Engineer at BOC Edwards Pharmaceutical Systems, examines the risks linked to the freeze-drying process and the new developments that are underway to overcome them, in Freeze-Drying of Potent Compounds |
|
|
| What does the future hold for Western API suppliers given the increasing prominence of India and China in this field? Charles Dods, Marketing Director at Aesica Pharmaceuticals Limited, addresses this pertinent question, in API Manufacturing - Still a Place for Western Suppliers? |
|
|
|
| In Blow Fill-Seal - A Technology for Producing Single Dose Liquid Medicines, Tony Garner, Head of Business Development at Boehringer Ingelheim, argues that blow fill-seal is a manufacturing process well suited to producing single doses of sterile medicine, providing advantages for both carer and patient |
|
|
| Unlike most injectable medical products, there are two processes available for the packaging of prefilled syringes; M Jean Pierre Merceille, Technical Director at Stelmi, compares these methods, in Ready-to-Use Primary Packaging Materials: An Example of Prefilled Syringe Plungers |
|
|
| Claudia Petersen, Senior Manager, Biotechnology, and Dr Mike Schefers, Director, Scientific and Technical Customer Service Europe/Asia-Pacific at West Pharmaceutical Services, describe the rebirth of 'ready-to-sterilise' elastomeric components, in Clean, Validated and 'Ready to Sterilise' Elastomeric Components Make Their Claim |
|
|
|
| In Particle Shape: An Important Parameter in Pharmaceutical Manufacturing, Carl Crompton, Product Manager, Vision Systems at Malvern Instruments Ltd, argues that in recent years particle shape has become as important in the development of pharmaceutical manufacturing as particle size |
|
|
| Rob O'Connell, Marketing Manager at Russell Finex Ltd, claims that sieving is generally a low priority when it comes to pharmaceutical plants investing money, and he outlines why this process is essential, in Ultrasonic Deblinding |
|
|
|
Dr A Robert Neurath, Head of the Laboratory of Biochemical Virology at the New York Blood Center, and Scott Barnhart, R&D Leader for the Pharmaceutical Business Unit at Adhesive Research, present a new technology that could prevent the spread of HIV and other sexually transmitted diseases, in Water-Dispersible Microbicidal Films for Prevention of HIV-1 and Sexually Transmitted Diseases
|
|
|
| It is vital to bring a drug to market quickly, assert Harry Clark, Chief Executive Officer of SI Associates, Inc and John Gallacher, Operations Director of SI Associates Ltd, in Optimising the Process for the Design, Development and Introduction of (Electro-) Mechanical Drug Delivery Devices |
|
|
|
| In Safety Assessment and CMC Testing of Pulmonary Delivery Systems, Gillian Johnson, Manager of the Pharmaceutical Analysis Group at Covance Laboratories and Richard Crowley, Senior Science Writer and Editor of the Covance publication Evolution, explore the key components in the successful development of new drugs |
|
|
| Jean Martin Larran, General Manager of Micron Technologies Ltd, looks at pharmaceutical powders in inhalation, in Micronisation of Pharmaceutical Powders for Use in Inhalation |
|
|
| In The Challenge of the New: Device-Formulation Matching in Dry Powder Inhaler Systems, David A V Morton and John N Staniforth at Vectura Group plc, investigate the challenge of developing an efficient inhalation system |
|
|
| HFA 227ea (Heptafluoropropane/Apaflurane) and HFA 134a (Tetrafluoroethane/Norflurane) are being used by the pharmaceutical industry as propellants for medical aerosols. Peter Jannick, Process Engineer at Solvay Fluor GmbH, compares their uses, in Characteristics of the Hydrofluorocarbons HFA 227ea and HFA 134a for Medical Aerosols |
|
|
| Christian Husegaard, Head of Sales & Marketing at Bang & Olufsen Medicom, considers the use of inhalers in patient compliance, in Breathing New Life into Asthma Therapy: Customer- Oriented Inhaler Designs and Integrated Dose Counting Enhance Patient Compliance |
|
|
|
|
| When acquiring clinical trial materials, one of the greatest challenges in the supply chain relates to labelling, argues Todd Jusas, Vice President of Information Technology at Clintrak, in A Classic Problem with Labelling for Global Studies |
|
|
| After an unsure start, the popularity of outsourcing is growing, John Bath, CEO of Brecon Pharmaceuticals Ltd, looks at the relationship between customers and outsource providers, in Making the Move to Outsource Partnerships |
|
|
|
| The safety of a drug depends on its packaging. Helmut Hennig, Head of the System & Service Department, and Jochen Alberstetter, Head of Packaging, at Vetter Pharma-Fertigung, chart how syringes can be beneficial, in Anti-Counterfeiting Measures for the Pharmaceutical Industry |
|
|
| It is essential that genuine products are protected from illegal trade, says Alex Lewis, Head of AOT's Opsec Brand Protection business in the EMEA region, in Pharmaceutical Counterfeiting - The Threat to Consumer and Corporate Wellbeing |
|
|
| Cost saving is a preoccupation for pharmaceutical manufacturers during the logistics process. Katrina Bray, Marketing Manager at Laminar Medica Ltd, reviews a way of achieving this aim, in Making the Case for the Returnable Shipper |
|
|
| Maintaining standards of compliance in the supply chain are paramount, explains Nick Revell, Sector Director, Freight Management Healthcare, Europe Middle East and Africa and Anthony Mitchell, Senior Vice President, Healthcare Worldwide, at Exel, in Managing Temperature-Controlled Supply Chains for the Global Pharmaceutical Industry |
|
|
|
| PMPS talks to Rientz Bol, Director of Bolidt Synthetic Products & Systems in the Netherlands, to discover how the company has addressed the requirements of a uniform flooring system |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing
GOETTINGEN, Germany and GLASGOW, UK, August 08, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions. These services are offered by its subsidiary, Sartorius Stedim BioOutsource, an experienced contract testing organization (CTO) based in Glasgow, UK, and in Cambridge, Massachusetts, USA.
More info >> |
|
 |
White Papers |
 |
|
Preparation of Pharmaceutical Samples for Metals Analysis
RSSL
There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >> |
|
 |
Industry Events |
 |
SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)
11-13 May 2020, Copthorne Tara Hotel, London, UK
SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >> |
|
|
